137 related articles for article (PubMed ID: 37595449)
1. Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.
Yu W; Ding C; Li K
Oral Oncol; 2023 Nov; 146():106541. PubMed ID: 37595449
[TBL] [Abstract][Full Text] [Related]
2. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma ex pleomorphic adenoma of the parotid gland.
Park KS; Kim JH; Lee DH; Lee JK; Lim SC
Am J Otolaryngol; 2022; 43(2):103389. PubMed ID: 35149345
[TBL] [Abstract][Full Text] [Related]
7. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of carcinoma ex pleomorphic adenoma compared to de novo adenocarcinoma of major salivary glands.
Patel EJ; Oliver JR; Liu C; Tam M; Givi B
J Surg Oncol; 2021 Feb; 123(2):446-455. PubMed ID: 33145786
[TBL] [Abstract][Full Text] [Related]
9. Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland.
Quiroga EF; Connor PR; Rooper L; Moreno MA; Nix JS
Head Neck Pathol; 2023 Sep; 17(3):851-854. PubMed ID: 37594632
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of salivary gland pleomorphic adenoma: proof of principle.
Valstar MH; Mast H; Ten Hove I; Moonen LR; Balm AJ; Smeele LE; Koljenović S; Dinjens WN; van Velthuysen MF
J Pathol Clin Res; 2021 Sep; 7(5):432-437. PubMed ID: 34390320
[TBL] [Abstract][Full Text] [Related]
12. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland.
Zhao J; Wang J; Yu C; Guo L; Wang K; Liang Z; Lou J
World J Surg Oncol; 2013 Aug; 11(1):180. PubMed ID: 23924064
[TBL] [Abstract][Full Text] [Related]
15. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.
Singh K; Agarwal C; Pujani M; Verma P; Chauhan V
Diagn Cytopathol; 2017 Jul; 45(7):651-654. PubMed ID: 28261993
[TBL] [Abstract][Full Text] [Related]
17. Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.
Covinsky M; Cai Z; Ambelil M; Liu J; Zhu H
Head Neck Pathol; 2018 Mar; 12(1):82-88. PubMed ID: 28589437
[TBL] [Abstract][Full Text] [Related]
18. Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Thorpe LM; Schrock AB; Erlich RL; Miller VA; Knost J; Le-Lindqwister N; Jujjavarapu S; Ali SM; Liu JJ
Head Neck; 2017 Mar; 39(3):E40-E44. PubMed ID: 28006087
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
20. Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression.
Cormier C; Agarwal S
Head Neck Pathol; 2022 Mar; 16(1):322-330. PubMed ID: 34128136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
